Evidence-Based Complementary and Alternative Medicine / 2019 / Article / Tab 1

Research Article

Association of Patients’ Characteristics with Acupuncture Treatment Outcomes in Treating Bell’s Palsy: Results from a Randomised Controlled Trial

Table 1

HB grades of subjects at different stages of the disease according to the five acupuncture treatmentsa.

HB gradeTreatmentb
A N (%)B N (%)C N (%)D N (%)E N (%) value

Baseline period
 II16 (9.64)15 (9.09)19 (11.31)16 (10.00)16 (9.58)0.5911
 III58 (34.94)63 (38.18)61 (36.31)58 (36.25)71 (42.51)
 IV73 (43.98)67 (40.61)58 (34.52)54 (33.75)58 (34.73)
 V18 (10.84)20 (12.12)28 (16.67)31 (19.38)22 (13.17)
 VI1 (0.60)0 (0)2 (1.19)1 (0.63)0 (0)
 Total166165168160167
1-week acupuncture
 I1 (0.60)2 (1.21)1 (0.60)0 (0)0 (0)0.2993
 II38 (22.89)43 (26.06)38 (22.62)35 (21.88)33 (19.76)
 III77 (46.39)80 (48.48)70 (41.67)71 (44.38)90 (53.89)
 IV45 (27.11)32 (19.39)46 (27.38)47 (29.38)29 (17.37)
 V5 (3.01)8 (4.85)13 (7.74)7 (4.38)15 (8.98)
 Total166165168160167
2-week acupuncture
 I6 (3.61)8 (4.85)4 (2.38)1 (0.63)3 (1.80)0.6443
 II73 (43.98)76 (46.06)78 (46.43)73 (45.63)77 (46.11)
 III70 (42.17)58 (35.15)60 (35.71)63 (39.38)63 (37.72)
 IV16 (9.64)22 (13.33)21 (12.50)21 (13.13)21 (12.57)
 V1 (0.60)1 (0.61)5 (2.98)2 (1.25)3 (1.80)
 Total166165168160167
3-week acupuncture
 I14 (8.43)15 (9.09)14 (8.33)6 (3.75)7 (4.19)0.3617
 II112 (67.47)95 (57.58)103 (61.31)104 (65.00)111 (66.47)
 III29 (17.47)43 (26.06)39 (23.21)45 (28.13)33 (19.76)
 IV10 (6.02)12 (7.27)10 (5.95)4 (2.50)16 (9.58)
 V1 (0.60)0 (0)2 (1.19)1 (0.63)0 (0)
 Total166165168160167
4-week acupuncture
 I85 (51.20)87 (52.73)87 (51.79)75 (46.88)85 (50.90)0.5646
 II58 (34.94)54 (32.73)56 (33.33)57 (35.63)50 (29.94)
 III18 (10.84)19 (11.52)17 (10.12)24 (15.00)23 (13.77)
 IV4 (2.41)5 (3.03)7 (4.17)3 (1.88)9 (5.39)
 V1 (0.60)0 (0)1 (0.60)1 (0.63)0 (0)
 Total166165168160167
4-week follow-up
 I127 (76.51)124 (75.15)116 (69.05)120 (75.00)125 (74.85)0.6421
 II28 (16.87)33 (20.00)42 (25.00)30 (18.75)29 (17.37)
 III10 (6.02)8 (4.85)8 (4.76)9 (5.63)11 (6.59)
 IV0 (0)0 (0)2 (1.19)1 (0.63)2 (1.20)
 V1 (0.60)0 (0)0 (0)0 (0)0 (0)
 Total166165168160167
12-week follow-up
 I142 (85.54)144 (87.27)134 (79.76)137 (85.63)141 (84.43)0.3999
 II17 (10.24)18 (10.91)28 (16.67)18 (11.25)20 (11.98)
 III6 (3.61)3 (1.82)5 (2.98)4 (2.50)6 (3.59)
 IV0 (0)0 (0)1 (0.60)1 (0.63)0 (0)
 V1 (0.60)0 (0)0 (0)0 (0)0 (0)
 Total166165168160167

aData are expressed as the number of patients (%), unless otherwise indicated. bA indicates manual acupuncture, B indicates manual acupuncture + moxibustion, C indicates manual acupuncture + electroacupuncture, D indicates manual acupuncture + acupuncture along the yangming musculature, and E indicates manual acupuncture, regardless of which stage of the disease the patients were in.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.